Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Randomized Parallel Controlled Clinical Trial to Evaluate the Safety and Effectiveness of a Radiofrequency Renal Denervation System for the Treatment of Essential Hypertension

NCT03261375 is registered in ClinicalTrials.gov with Shanghai Golden Leaf MedTec Co. Ltd as lead sponsor.

NCT NCT03261375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03261375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Randomized Parallel Controlled Clinical Trial to Evaluate the Safety and Effectiveness of a Radiofrequency Renal Denervation System for the Treatment of Essential Hypertension
Lead sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Phase
Not applicable
Overall status
Completed
Start date
January 19, 2021
Completion date
December 26, 2022
Enrollment
205 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension